News

Aura Biosciences, a biotechnology company developing a new class of therapies to target and selectively destroy cancer cells using viral nanoparticle conjugates, announced that the U.S.…
Read More...

Strata Oncology announced an agreement with Epizyme to support patient identification and enrollment for Epizyme’s ongoing Phase 2 clinical trial of tazemetostat in patients with…
Read More...

Veeva Systems (VEEV) announced a new cloud application dubbed Veeva Vault Submissions Publishing that incorporates publishing capabilities within Veeva Vault RIM to accelerate…
Read More...

Portola Pharmaceuticals, Inc.® (PTLA) announced that it has signed a $150 million royalty agreement with HealthCare Royalty Partners (HCR). Under the terms of the agreement, Portola…
Read More...

Teva Pharmaceutical Industries Ltd., announced that it has filed an abbreviated new drug application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market…
Read More...

Lysogene announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to LYS-GM101, the company’s gene therapy drug candidate for treatment of GM1…
Read More...

Cocoon Biotech, Inc., is a biotechnology company focused on utilizing its silk protein-based drug delivery technology for the development of formulations to treat osteoarthritis and…
Read More...

GE Healthcare’s FlexFactory manufacturing platform has been selected to expand production capacity at Arven Pharmaceuticals' facility in Kirklareli, Turkey. With this expanded…
Read More...

HOPE BIOSCIENCES, INC. announced that it has acquired exclusive and worldwide rights to develop and commercialize HOPE 777, a unique MERTK/AXL/pan-c-MET tyrosine kinase inhibitor…
Read More...

Meridian Laboratories, Inc., a Buffalo, IL based specialty-oncology drug development company, announced today that it has entered into a definitive agreement with Apobiologix, a part of…
Read More...

Allergan plc announced that it has successfully completed the acquisition of LifeCell Corporation, a leading regenerative medicine company. Allergan acquired LifeCell for approximately…
Read More...

Abbott announced that US FDA (Food and Drug Administration) has granted authorization for RealTime ZIKA test, to detect Zika virus in whole Blood for emergency use. This is the first…
Read More...

GenSight Biologics, a biopharma company that discovers and develops innovative gene therapies for neurodegenerative retinal diseases and diseases of the central nervous system,…
Read More...

Ipsen announces that it has signed an agreement to take an equity stake in Akkadeas Pharma with an option to take control of the company in the future. Akkadeas Pharma is a…
Read More...

Noxopharm announces that it has entered into a research agreement with the University of Hong Kong to conduct research into the use of the drug idronoxil (NOX66 active ingredient) to…
Read More...

Medical researchers and IBM are asking for the public's help in identifying prospective treatments for childhood cancers. Scientists are searching for chemical drug candidates that…
Read More...

Every year, Gerresheimer’s pharmaceutical industry customers order several hundreds of millions of glass pharmaceutical packaging products manufactured at the company’s plants in Essen…
Read More...

Astellas Pharma Inc. and Ironwood Pharmaceuticals, Inc. announced top-line results indicating that the Phase III clinical trial of linaclotide conducted in Japan in adults with chronic…
Read More...

Endo International plc announced that one of its operating companies, Par Pharmaceutical has received final approval from the U.S. Food and Drug Administration for its New Drug…
Read More...

Ferring Pharmaceuticals and Enteris BioPharma, Inc. announced that the companies have entered into a license agreement and initiated an early development agreement to leverage Enteris'…
Read More...